GC Biopharma’s Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in ‘Vaccine’03/11/2025PR Newswire
BECIS announces US$45 million in new equity financing from shareholders to drive next phase of scalable growth03/11/2025PR Newswire
Biomom Reinvents “Snow” with Five-Layer Safety Packaging — Stronger Protection and Greater Convenience for Kids’ Probiotics03/11/2025PR Newswire
RLX Technology to Report Third Quarter 2025 Financial Results on November 14, 202503/11/2025PR Newswire
LEPAS Shines at the 2025 Chery International User Summit, Where “Technology Meets Elegance” to Define a New Way of Life03/11/2025PR Newswire
Legal Innovation Asia 2026 Report Reveals GenAI Transforming Legal Work, But Human Expertise Remains Central03/11/2025PR Newswire
MALAYSIA HEALTHCARE TRAVEL COUNCIL STRENGHTENS REGIONAL PRESENCE IN MEDAN THROUGH ASTINDO TRAVEL FAIR 202503/11/2025PR Newswire
